Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
TriSalus Life Sciences Inc.
TLSICurrent price
4.01 USD
-0.59 USD (-12.83%)
Last closed
4.46 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
128 977 352 USD
Yield for 12 month
+2.30 %
1Y
3Y
5Y
10Y
15Y
TLSI
TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado. Address: 6272 West 91st Avenue, Westminster, CO, United States, 80031
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.3 USDP/E ratio
0.081Dividend Yield
–Current Year
+18 511 000 USD
Last Year
+12 398 000 USD
Current Quarter
+7 364 000 USD
Last Quarter
+6 457 000 USD
Current Year
+15 906 000 USD
Last Year
+10 140 000 USD
Current Quarter
+6 258 000 USD
Last Quarter
+5 486 000 USD
Key Figures TLSI
1 year
3 years
5 years
10 years
EBITDA
-51 704 000 USD
Operating Margin TTM
PE Ratio
0.081
Return On Assets TTM
-133.15 %
PEG Ratio
–
Return On Equity TTM
-496.21 %
Wall Street Target Price
12.3 USD
Revenue TTM
24 736 000 USD
Book Value
-0.89 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
59.7 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
52.25 USD
Diluted Eps TTM
52.25 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-219.71 %
Dividend Analytics TLSI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TLSI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation TLSI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.081
Forward PE
–
Enterprise Value Revenue
5.4681
Price Sales TTM
5.2142
Enterprise Value EBITDA
-5.9552
Price Book MRQ
30.2854
Financials TLSI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators TLSI
For 52 weeks
3.32 USD
10.42 USD
50 Day MA
4.41 USD
Shares Short Prior Month
51 196
200 Day MA
7.05 USD
Short Ratio
1.42
Shares Short
62 124
Short Percent
0.37 %
BeatStart